{"title":"成人心肺复苏过程中使用皮质类固醇的临床益处:一项系统回顾和荟萃分析。","authors":"Wachira Wongtanasarasin, Sarunsorn Krintratun","doi":"10.5492/wjccm.v10.i5.290","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The clinical benefits of steroid administration during cardiac arrest remain unclear. Several studies reported that patients who received steroids after achieving a return of spontaneous circulation (ROSC) had better outcomes, but few studies have investigated the benefits of steroid administration during resuscitation. We hypothesized that administration of steroid during cardiac arrest would be associated with better clinical outcomes in adults with cardiac arrest.</p><p><strong>Aim: </strong>To investigate the effect of steroid administration during cardiac arrest and the outcomes of resuscitation.</p><p><strong>Methods: </strong>We included studies of participants older than 18 years of age who experienced cardiac arrest and included at least one arm that received corticosteroids during cardiac arrest. A literature search of PubMed and Embase on 31 January 2021 retrieved placebo-controlled studies without limitation for type, location, and initial presenting rhythm of cardiac arrest. The study outcomes were reported by odds ratios (ORs) compared with placebo. The primary outcome was survival rate at hospital discharge. Secondary outcomes included a sustained ROSC, survival rate at hospital admission, and neurological outcome at hospital discharge.</p><p><strong>Results: </strong>Six studies including 146262 participants were selected for analysis. The risk of bias ranged from low to high for randomized-controlled trials (RCTs) and low (for non-RCTs). Steroid administration was associated with increased survival at hospital discharge [OR: 3.51, 95% confidence interval (CI): 1.98-6.20, <i>P</i> < 0.001], and steroid administration during cardiac arrest was associated with both an increased rate of sustained ROSC (OR: 1.81, 95%CI: 1.91-4.02, <i>P</i> < 0.001) and a favorable neurological outcome at hospital discharge (OR: 3.02, 95%CI: 1.26-7.24, <i>P</i> = 0.01).</p><p><strong>Conclusion: </strong>Steroid administration during cardiac arrest was associated with better outcomes of resuscitation. Further study of the use of steroid in the selected circumstances are warranted.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":"10 5","pages":"290-300"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f3/f0/WJCCM-10-290.PMC8462020.pdf","citationCount":"2","resultStr":"{\"title\":\"Clinical benefits of corticosteroid administration during adult cardiopulmonary resuscitation: A systemic review and meta-analysis.\",\"authors\":\"Wachira Wongtanasarasin, Sarunsorn Krintratun\",\"doi\":\"10.5492/wjccm.v10.i5.290\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The clinical benefits of steroid administration during cardiac arrest remain unclear. Several studies reported that patients who received steroids after achieving a return of spontaneous circulation (ROSC) had better outcomes, but few studies have investigated the benefits of steroid administration during resuscitation. We hypothesized that administration of steroid during cardiac arrest would be associated with better clinical outcomes in adults with cardiac arrest.</p><p><strong>Aim: </strong>To investigate the effect of steroid administration during cardiac arrest and the outcomes of resuscitation.</p><p><strong>Methods: </strong>We included studies of participants older than 18 years of age who experienced cardiac arrest and included at least one arm that received corticosteroids during cardiac arrest. A literature search of PubMed and Embase on 31 January 2021 retrieved placebo-controlled studies without limitation for type, location, and initial presenting rhythm of cardiac arrest. The study outcomes were reported by odds ratios (ORs) compared with placebo. The primary outcome was survival rate at hospital discharge. Secondary outcomes included a sustained ROSC, survival rate at hospital admission, and neurological outcome at hospital discharge.</p><p><strong>Results: </strong>Six studies including 146262 participants were selected for analysis. The risk of bias ranged from low to high for randomized-controlled trials (RCTs) and low (for non-RCTs). Steroid administration was associated with increased survival at hospital discharge [OR: 3.51, 95% confidence interval (CI): 1.98-6.20, <i>P</i> < 0.001], and steroid administration during cardiac arrest was associated with both an increased rate of sustained ROSC (OR: 1.81, 95%CI: 1.91-4.02, <i>P</i> < 0.001) and a favorable neurological outcome at hospital discharge (OR: 3.02, 95%CI: 1.26-7.24, <i>P</i> = 0.01).</p><p><strong>Conclusion: </strong>Steroid administration during cardiac arrest was associated with better outcomes of resuscitation. Further study of the use of steroid in the selected circumstances are warranted.</p>\",\"PeriodicalId\":66959,\"journal\":{\"name\":\"世界危重病急救学杂志(英文版)\",\"volume\":\"10 5\",\"pages\":\"290-300\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f3/f0/WJCCM-10-290.PMC8462020.pdf\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"世界危重病急救学杂志(英文版)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5492/wjccm.v10.i5.290\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"世界危重病急救学杂志(英文版)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5492/wjccm.v10.i5.290","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
摘要
背景:在心脏骤停期间使用类固醇的临床益处尚不清楚。一些研究报道,在实现自发循环恢复(ROSC)后接受类固醇治疗的患者有更好的结果,但很少有研究调查复苏期间类固醇治疗的益处。我们假设在心脏骤停期间使用类固醇与心脏骤停成人患者更好的临床结果相关。目的:探讨类固醇药物对心脏骤停患者复苏的影响。方法:我们纳入了18岁以上经历过心脏骤停的参与者的研究,包括至少一支在心脏骤停期间接受皮质类固醇治疗的研究。2021年1月31日,PubMed和Embase的文献检索检索了安慰剂对照研究,不限制心脏骤停的类型、位置和初始呈现节律。研究结果通过与安慰剂比较的优势比(ORs)报告。主要观察指标为出院时的生存率。次要结局包括持续ROSC、住院时的生存率和出院时的神经预后。结果:共选取6项研究146262名受试者进行分析。随机对照试验(rct)的偏倚风险从低到高到低(非rct)。类固醇给药与出院时生存率增加相关[OR: 3.51, 95%可信区间(CI): 1.98-6.20, P < 0.001],心脏骤停期间类固醇给药与持续ROSC发生率增加(OR: 1.81, 95%CI: 1.91-4.02, P < 0.001)和出院时良好的神经预后相关(OR: 3.02, 95%CI: 1.26-7.24, P = 0.01)。结论:在心脏骤停期间使用类固醇与较好的复苏结果相关。有必要在选定的情况下进一步研究类固醇的使用。
Clinical benefits of corticosteroid administration during adult cardiopulmonary resuscitation: A systemic review and meta-analysis.
Background: The clinical benefits of steroid administration during cardiac arrest remain unclear. Several studies reported that patients who received steroids after achieving a return of spontaneous circulation (ROSC) had better outcomes, but few studies have investigated the benefits of steroid administration during resuscitation. We hypothesized that administration of steroid during cardiac arrest would be associated with better clinical outcomes in adults with cardiac arrest.
Aim: To investigate the effect of steroid administration during cardiac arrest and the outcomes of resuscitation.
Methods: We included studies of participants older than 18 years of age who experienced cardiac arrest and included at least one arm that received corticosteroids during cardiac arrest. A literature search of PubMed and Embase on 31 January 2021 retrieved placebo-controlled studies without limitation for type, location, and initial presenting rhythm of cardiac arrest. The study outcomes were reported by odds ratios (ORs) compared with placebo. The primary outcome was survival rate at hospital discharge. Secondary outcomes included a sustained ROSC, survival rate at hospital admission, and neurological outcome at hospital discharge.
Results: Six studies including 146262 participants were selected for analysis. The risk of bias ranged from low to high for randomized-controlled trials (RCTs) and low (for non-RCTs). Steroid administration was associated with increased survival at hospital discharge [OR: 3.51, 95% confidence interval (CI): 1.98-6.20, P < 0.001], and steroid administration during cardiac arrest was associated with both an increased rate of sustained ROSC (OR: 1.81, 95%CI: 1.91-4.02, P < 0.001) and a favorable neurological outcome at hospital discharge (OR: 3.02, 95%CI: 1.26-7.24, P = 0.01).
Conclusion: Steroid administration during cardiac arrest was associated with better outcomes of resuscitation. Further study of the use of steroid in the selected circumstances are warranted.